Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
7.64
+0.04 (0.53%)
At close: Jul 11, 2025, 4:00 PM
7.67
+0.03 (0.39%)
After-hours: Jul 11, 2025, 8:00 PM EDT
Cybin Employees
Cybin had 50 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,574,244
Market Cap
175.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CYBN News
- 10 days ago - REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures - Business Wire
- 11 days ago - Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 11 days ago - Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures - Business Wire
- 4 weeks ago - Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics - Business Wire
- 4 weeks ago - Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference - Business Wire
- 4 weeks ago - Cybin to Participate in the 2025 Psychedelic Science Conference - Business Wire
- 5 weeks ago - Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder - Business Wire
- 7 weeks ago - Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025 - Business Wire